Ixazomib Maintenance Study in Patients With AL Amyloidosis
Clinical trial NCT03618537 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03618537
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2026-08-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.